Selvas Healthcare셀바스헬스케어
208370 · KOSDAQ · ₩208370 · 셀바스헬스케어
₩2,110▼ ₩70 (3.21%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩31B | ₩32B | ₩30B | ₩28B | ₩29B |
| Cost of sales | ₩16B | ₩15B | ₩14B | ₩14B | ₩15B |
| Gross profit | ₩15B | ₩17B | ₩16B | ₩14B | ₩14B |
| Operating income | −₩162M | ₩3.3B | ₩3.3B | ₩2.3B | ₩3.4B |
| Net income | ₩3.9B | ₩3.2B | ₩5.2B | ₩2.7B | ₩2.5B |
| Net income to shareholders | ₩3.9B | ₩3.2B | ₩5.2B | ₩2.7B | ₩2.5B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩79B | ₩70B | ₩67B | ₩45B | ₩49B |
| Current assets | ₩46B | ₩44B | ₩41B | ₩21B | ₩26B |
| Cash and equivalents | ₩9.4B | ₩14B | ₩9.8B | ₩4.4B | ₩9.9B |
| Total liabilities | ₩7.9B | ₩6.4B | ₩6.6B | ₩12B | ₩21B |
| Current liabilities | ₩5B | ₩5.4B | ₩6.1B | ₩8.8B | ₩17B |
| Borrowings | ₩1.1B | ₩2.3B | ₩2.9B | ₩7.5B | ₩9B |
| Total equity | ₩71B | ₩64B | ₩60B | ₩33B | ₩28B |
| Shareholders' equity | ₩71B | ₩64B | ₩60B | ₩33B | ₩28B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | ₩305M | ₩4.5B | ₩3.5B | ₩51M | ₩2.9B |
| Capital spending | ₩857M | ₩716M | ₩360M | ₩352M | ₩371M |
| Free cash flow | −₩552M | ₩3.8B | ₩3.1B | −₩302M | ₩2.6B |
Consolidated where available. Amounts in won.
Also known as: Selvas Healthcare / 셀바스헬스케어 / 208370 / KRX:208370
Source: KRX statistical information